Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent vs Sequential Cetuximab with Chemotherapy in Advanced NSCLC
NCT00085501Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 2004
- Primary completion
- Aug 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Started Jul 2004; status: completed.
02
Drugs
KL-140
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00085501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085501.